Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.

Cancer journal (Sudbury, Mass.) - 1 Jan 2000

Laframboise S, Chapman W, McLaughlin J, Andrulis I L

Abstract excerpt

PURPOSE: The investigators undertook a retrospective study to determine (1) whether p53 mutations are predictors of survival in patients with advanced epithelial ovarian cancer, (2) whether p53 status by sequencing is associated with established prognostic indicators, and (3) the agreement of results between direct sequencing of p53 mutations and immunohistochemistry. MATERIAL AND METHODS: This study was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Phytogenic
Share to Cisplatin
Share to Codon

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Genes, p53

Share to Neoplasms, Glandular and Epithelial

Share to Ovarian Neoplasms

Share to Paclitaxel

Source

Identifiers

PMID: 11079169

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.PMID 11079169Read ↗

Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study.Semantic proximity Read ↗

Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.Semantic proximity Read ↗

p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study.Semantic proximity Read ↗

Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations.Semantic proximity Read ↗

Functional validation of somatic variability in TP53 and KRAS for prediction of platinum sensitivity and prognosis in epithelial ovarian carcinoma patientsSemantic proximity Read ↗

A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors.Semantic proximity Read ↗

P53 mutation in a series of epithelial ovarian cancers from the U.K., and its prognostic significance.Semantic proximity Read ↗

p53 mutations and expression in ovarian cancers: correlation with overall survival.Semantic proximity Read ↗

P53 mutation does not affect prognosis in ovarian epithelial malignancies.Semantic proximity Read ↗

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.Semantic proximity Read ↗

A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma.Semantic proximity Read ↗

The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus ImmunohistochemistrySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.